Biogen Inc
Change company Symbol lookup
Select an option...
BIIB Biogen Inc
BAC Bank of America Corp
INCT Incapta Inc
HAYN Haynes International Inc
MLSS Milestone Scientific Inc
IMKTA Ingles Markets Inc
III Information Services Group Inc
HVRRY Hannover Rueck SE
HVRRF Hannover Rueck SE
HNFSB Hanover Foods Corp
Go

Health Care : Biotechnology | Large Cap ValueCompany profile

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Closing Price
$282.27
Day's Change
7.12 (2.59%)
Bid
--
Ask
--
B/A Size
--
Day's High
283.95
Day's Low
277.11
Volume
(Above Average)
Volume:
1,922,192

10-day average volume:
1,609,191
1,922,192
  • Prev Close
    275.15
  • Today's Open
    278.25
  • Day's Range
    277.11-283.95
  • Avg Vol (10-day)
    1.6M
  • Last (time)
    4:00p ET 11/15/19
  • Last (size)
    20
  • 52-Wk Range
    215.78 - 344.00
    LowHigh
  • (01/23/19 - 09/04/19)
    17.94%
  • 49.6%
  • Market Cap
    50.9B
  • Shares Outstanding
    180.4M
  • 28.24
  • 10.00x
  • No dividend
  • Ex-dividend
    No dividend
  • 1.1
  • 89.27
  • (% of float 10/31/19)
    2.23

Latest News

November 14, 2019
3:08 pm ET
MarketWatch
November 12, 2019
7:00 am ET
PR Newswire
November 06, 2019
8:20 am ET
MarketWatch
8:00 am ET
BusinessWire
7:52 am ET
MarketWatch
7:51 am ET
MarketWatch
7:46 am ET
BusinessWire
November 04, 2019
4:30 pm ET
Globe Newswire
October 30, 2019
2:33 pm ET
MarketWatch
7:40 am ET
MarketWatch
7:33 am ET
MarketWatch
7:30 am ET
Globe Newswire
7:30 am ET
PR Newswire
October 25, 2019
9:00 am ET
PR Newswire
October 23, 2019
9:31 am ET
PR Newswire
8:23 am ET
MarketWatch
7:27 am ET
MarketWatch
October 22, 2019
5:48 pm ET
MarketWatch
11:49 am ET
MarketWatch
11:08 am ET
MarketWatch
11:08 am ET
MarketWatch
11:08 am ET
MarketWatch
6:57 am ET
MarketWatch
6:57 am ET
MarketWatch
6:56 am ET
MarketWatch
6:30 am ET
Globe Newswire
October 21, 2019
7:30 am ET
Globe Newswire
October 12, 2019
12:26 pm ET
MarketWatch
October 02, 2019
11:21 am ET
MarketWatch
7:30 am ET
Globe Newswire
October 01, 2019
8:07 am ET
Globe Newswire
8:06 am ET
MarketWatch
8:02 am ET
MarketWatch
September 23, 2019
3:00 am ET
Globe Newswire
September 18, 2019
7:30 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.